Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET.

作者: Henryk Barthel , Osama Sabri , None

DOI: 10.3233/JAD-2011-0068

关键词:

摘要: PET imaging of amyloid-β has recently emerged as a valuable biomarker to support the in vivo diagnosis Alzheimer's disease (AD). So far, however, no tracer is available suitable for general clinical routine application. Florbetaben promising 18F-labeled amyloid-β-targeted currently Phase 2/3 development. This review provides an overview on current knowledge and future research activities florbetaben. Recently, first worldwide multi-center trial test diagnostic performance AD was conducted with this tracer. From trial, sensitivity specificity 80 91% discrimination between patients probable age-matched healthy controls reported. Ongoing florbetaben trials deal correlating signal post mortem histopathology evaluation, investigating value predict progression at stage mild cognitive impairment. The preclinical data verify safe efficacious detection deposition brain. results ongoing will contribute characteristics florbetaben, help determine potential visual adjunct supplement "AD toolbox".

参考文章(11)
G. J. O'Keefe, T. H. Saunder, S. Ng, U. Ackerman, H. J. Tochon-Danguy, J. G. Chan, S. Gong, T. Dyrks, S. Lindemann, G. Holl, L. Dinkelborg, V. Villemagne, C. C. Rowe, Radiation Dosimetry of β-Amyloid Tracers 11C-PiB and 18F-BAY94-9172 The Journal of Nuclear Medicine. ,vol. 50, pp. 309- 315 ,(2009) , 10.2967/JNUMED.108.055756
Wei Zhang, Shunichi Oya, Mei-Ping Kung, Catherine Hou, Donna L. Maier, Hank F. Kung, F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain Nuclear Medicine and Biology. ,vol. 32, pp. 799- 809 ,(2005) , 10.1016/J.NUCMEDBIO.2005.06.001
M. Patt, A. Schildan, H. Barthel, G. Becker, M. H. Schultze-Mosgau, B. Rohde, C. Reininger, O. Sabri, Metabolite analysis of [18F]Florbetaben (BAY 94-9172) in human subjects: a substudy within a proof of mechanism clinical trial Journal of Radioanalytical and Nuclear Chemistry. ,vol. 284, pp. 557- 562 ,(2010) , 10.1007/S10967-010-0514-8
Henryk Barthel, Julia Luthardt, Georg Becker, Marianne Patt, Eva Hammerstein, Kristin Hartwig, Birk Eggers, Bernhard Sattler, Andreas Schildan, Swen Hesse, Philipp M Meyer, Henrike Wolf, Torsten Zimmermann, Joachim Reischl, Beate Rohde, Hermann-Josef Gertz, Cornelia Reininger, Osama Sabri, None, Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 38, pp. 1702- 1714 ,(2011) , 10.1007/S00259-011-1821-1
K. Jellinger, W. Danielczyk, P. Fischer, E. Gabriel, Clinicopathological analysis of dementia disorders in the elderly Journal of the Neurological Sciences. ,vol. 95, pp. 239- 258 ,(1990) , 10.1016/0022-510X(90)90072-U
Bruno Dubois, Howard H Feldman, Claudia Jacova, Steven T DeKosky, Pascale Barberger-Gateau, Jeffrey Cummings, André Delacourte, Douglas Galasko, Serge Gauthier, Gregory Jicha, Kenichi Meguro, John O'Brien, Florence Pasquier, Philippe Robert, Martin Rossor, Steven Salloway, Yaakov Stern, Pieter J Visser, Philip Scheltens, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria Lancet Neurology. ,vol. 6, pp. 734- 746 ,(2007) , 10.1016/S1474-4422(07)70178-3
W. A. Kukull, E. B. Larson, B. V. Reifler, T. H. Lampe, M. S. Yerby, J. P. Hughes, The validity of 3 clinical diagnostic criteria for Alzheimer's disease Neurology. ,vol. 40, pp. 1364- 1364 ,(1990) , 10.1212/WNL.40.9.1364
Bruno Dubois, Howard H Feldman, Claudia Jacova, Jeffrey L Cummings, Steven T DeKosky, Pascale Barberger-Gateau, André Delacourte, Giovanni Frisoni, Nick C Fox, Douglas Galasko, Serge Gauthier, Harald Hampel, Gregory A Jicha, Kenichi Meguro, John O'Brien, Florence Pasquier, Philippe Robert, Martin Rossor, Steven Salloway, Marie Sarazin, Leonardo C de Souza, Yaakov Stern, Pieter J Visser, Philip Scheltens, Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurology. ,vol. 9, pp. 1118- 1127 ,(2010) , 10.1016/S1474-4422(10)70223-4
Christopher C Rowe, Uwe Ackerman, William Browne, Rachel Mulligan, Kerryn L Pike, Graeme O'Keefe, Henry Tochon-Danguy, Gordon Chan, Salvatore U Berlangieri, Gareth Jones, Kerryn L Dickinson-Rowe, Hank P Kung, Wei Zhang, Mei Ping Kung, Daniel Skovronsky, Thomas Dyrks, Gerhard Holl, Sabine Krause, Matthias Friebe, Lutz Lehman, Stefanie Lindemann, Ludger M Dinkelborg, Colin L Masters, Victor L Villemagne, Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism Lancet Neurology. ,vol. 7, pp. 129- 135 ,(2008) , 10.1016/S1474-4422(08)70001-2
William E. Klunk, Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P. Holt, Mats Bergström, Irina Savitcheva, Guo-Feng Huang, Sergio Estrada, Birgitta Ausén, Manik L. Debnath, Julien Barletta, Julie C. Price, Johan Sandell, Brian J. Lopresti, Anders Wall, Pernilla Koivisto, Gunnar Antoni, Chester A. Mathis, Bengt Långström, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology. ,vol. 55, pp. 306- 319 ,(2004) , 10.1002/ANA.20009